查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
經皮給藥系統市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍：按類型、應用和配銷通路
市場調查報告書
商品編碼
1389614

經皮給藥系統市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍：按類型、應用和配銷通路

Transdermal Drug Delivery System Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type, Application, and Distribution Channel
出版日期: | 出版商: The Insight Partners | 英文 233 Pages | 訂單完成後即時交付

價格

全球經皮給藥系統市場預計將從2022年的372.3億美元增至2030年的519.49億美元。預計2022年至2030年該市場將以4.3%的CAGR成長。

推動市場成長的關鍵因素包括經皮給藥系統應用領域的不斷擴大和脊髓損傷病例的增加。然而，術後併發症阻礙了市場的成長。

經皮給藥系統市場的市場機會

經皮給藥途徑是新穎的，也是持續給藥的可靠方法之一。隨著這一領域的大量研究的開展以及研究人員對這種藥物輸送形式的興趣日益濃厚，未來可能會有大量經皮貼片進入市場。經皮貼片用於輸送尼古丁、芬太尼、硝酸甘油和可樂定等藥物來治療各種疾病。最近，這些貼片已被探索在各種應用中提供生物製劑。智慧貼片配備了感測器和其他技術來監測患者狀況並相應調整藥物傳遞。 2023 年 1 月，斯旺西大學的一位首席科學家開發了一種新型智慧貼片，利用微針技術檢測帕金森氏症和阿茲海默症等神經退化性疾病的促炎生物標記。這些智慧貼片包含大量微針，旨在以微創方式穿經皮膚屏障，然後監測具有臨床意義的生物標記。它們可以在全科診所或家中自我管理以進行即時診斷。這項創新研究可能會改變早期神經退化性疾病檢測的格局。

根據2021年11月發表在美國國家醫學圖書館的一篇題為《局部皮膚應用的3D列印產品：從個人化敷料到藥物輸送》的文章稱，貼合皮膚表面的個人化3D列印貼片可用於乙醯化-六肽3 (AHP-3) 遞送。在這項研究中，兩種液體單體——聚乙二醇二丙烯酸酯（PEGDA）和乙烯基吡咯烷酮（VP）——以不同的比例使用，以提高最終聚合物的機械強度、聚合速率和溶脹速率。樹脂上的最佳載藥量表明 AHP-3 在整個製造過程中保持穩定，並且對最終聚合物的物理性能沒有影響。使用 3D 掃描臉部模型，在電腦輔助設計軟體中設計個人化貼片，並使用數位光處理 3D 列印機在最佳化樹脂中製造。製備的經皮貼片的體外表徵表明它們能夠穿透人體屍體皮膚，並在壓縮後進一步保持完整。 「用於局部皮膚應用的3D 列印產品：從個人化敷料到藥物輸送」是第一個展示使用光聚合物製成的個人化貼片的研究，它引入了一種改善藥物經皮輸送的新方法，以實現有效的皺紋管理。

因此，3D列印技術和智慧貼片的採用可能會在未來幾年為經皮給藥系統市場提供機會。

阻礙經皮給藥系統市場的因素

目前市售的經皮給藥系統（TDDS）、透黏膜給藥系統（TMDS）和局部貼片在預期使用期後可能會保留初始藥物總量的10-95%作為殘留藥物。這給患者及其家人和照護者帶來了潛在的安全問題。例如，由於患者在預期使用期結束時未能去除TDDS而導致的不良事件通常會導致藥物的藥理作用增加或延長。據報道，一些兒童因意外接觸廢棄的 TDDS 而死亡。以下是製造商召回和撤回的一些產品。

2023 年 2 月，Aveva Drug Delivery Systems Inc 因不符合雜質/分解規格而召回了兩批丁丙諾啡經皮系統。 Aveva 藥物輸送系統於 2023 年 2 月 15 日主動啟動召回，並於 2023 年 3 月 14 日被 FDA 指定為 III 級召回。在此召回分類下，該產品的使用不太可能造成任何重大危害。 2020年9月，美國梯瓦製藥公司召回了兩批丁丙諾啡貼片。此次召回涉及批次190017 和190161 的32,543 箱丁丙諾啡經皮系統，5 微克/小時，每箱四個經皮系統（補丁NDC 0093-3656-21，紙箱NDC 0093-3656-40）。該產品由3M 製造梯瓦製藥 (Teva Pharmaceuticals) 的給藥系統，在美國和波多黎各分銷。繼 Teva Pharmaceuticals 於 2020 年 9 月 4 日自願召回後，FDA 於 2020 年 10 月 1 日將召回指定為 II 級。繼續使用 II 級召回產品可能會導致暫時或醫學上可逆的不良健康後果。雖然距離遙遠，但存在造成嚴重傷害的可能性。此外，2018 年 4 月，FDA 向 Phase 4 Pharmaceutical LLC 發出警告信。該公司不是生產經皮藥物類型，而是作為非處方 (OTC) 經皮藥物類型的重新包裝商，FDA 發現了幾項違反 CGMP 的行為，影響了其產品品質。 2019 年 4 月，Alvogen, Inc. 宣佈在全國範圍內自願召回兩批（或批次）芬太尼經皮系統（12 微克/小時經皮貼劑），原因是標籤混淆。因此，經皮給藥系統的不良反應和召回阻礙了市場的成長。

經皮給藥系統市場：細分概述

根據產品，經皮給藥系統市場分為經皮貼片、經皮凝膠、經皮噴霧等。經皮貼片細分為藥物貼片貼片、儲庫膜貼片、基質貼片及蒸氣貼片。經皮貼片細分市場在 2022 年佔據最大市場佔有率，而經皮凝膠預計在 2022 年至 2030 年期間複合CAGR最高。經皮貼片是附著在患者皮膚上以透過皮膚輸送藥物的藥物傳遞系統。

經皮給藥系統市場按應用細分為心血管疾病、中樞神經系統疾病、荷爾蒙應用、疼痛管理和其他應用。疼痛管理市場細分為鴉片類藥物應用和非鴉片類藥物應用。荷爾蒙應用領域的市場進一步細分為經皮雌激素療法和睪固酮替代療法。疼痛管理細分市場在 2022 年佔據最大市場佔有率。中樞神經系統疾病細分市場預計在 2022 年至 2030 年期間將實現最高的CAGR。

根據配銷通路，經皮給藥系統市場分為醫院藥房、零售藥房、網路藥房等。醫院藥局細分市場在 2022 年佔據最大市場佔有率。然而，零售藥局細分市場預計在 2022 年至 2030 年期間將實現最高的CAGR。

經皮給藥系統市場：地理概況

2022年，北美在全球經皮給藥系統市場中佔據最大佔有率。在該地區，美國擁有最大的經皮給藥系統市場佔有率，預計2022-2030年CAGR最高。根據美國心臟協會 (AHA) 的數據，心血管疾病 (CVD) 仍然是美國的首要死因。據 CDC 稱，2021 年，CVD 導致美國約 695,000 人死亡，約占美國五分之一的死亡人數。心血管疾病、糖尿病、慢性疼痛和其他慢性疾病的盛行率不斷上升，推動了對有效、便利的治療方案的需求。醫療貼片提供了一種非侵入性且患者友善的方法來提供藥物並管理與這些慢性病相關的症狀。 TDDS 的不斷進步，例如穿戴式感測器和軟性電子產品，有助於經皮給藥系統市場的成長。這些進步可以實現更準確的劑量、增強的患者監測並提高患者的依從性。根據Biomaterials Research 2021 年發表的題為《經皮給藥系統的最新進展》的報告，微針在TDDS 模式中引起了極大關注，它結合了微針的優點，克服了現有簡單塗抹型和貼片型針的限制。微針以獲得更高的治療效率和效果。這些TDDS的進展可以為控制心血管和中樞神經系統疾病、糖尿病、神經肌肉疾病以及傳染病和局部傳染病的流行提供動力。

個性化藥物的不斷成長趨勢，即針對個別患者量身定做治療方案，促進了提供受控和有針對性的藥物輸送的醫療貼劑的開發。這種客製化可以改善患者的治療效果並提高治療效果。例如，2020年，Reddy's Laboratories在美國市場推出了NitroDur（硝化甘油）經皮輸注系統的授權學名藥。隨著人們對家庭醫療保健和遠端患者監測的日益重視，醫療貼片為在傳統醫療保健環境之外輸送藥物和監測生命徵象提供了便捷的解決方案。美國經皮給藥系統市場受到慢性病盛行率上升、技術進步以及對個人化藥物日益關注等因素的影響。

在準備經皮給藥系統市場報告時提到的一些主要一手和二手來源包括世界銀行數據、國家衛生服務體系 (NHS)、FDA（食品和藥物管理局）、EMA（歐洲藥品管理局）、和WHO（世界衛生組織）。

目錄

第 1 章：簡介

  • Insight Partners 研究報告指南
  • 市場區隔

第 2 章：執行摘要

  • 重要見解
  • 經皮給藥系統市場（按地域）

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：經皮給藥系統市場格局

  • 概述
  • 全球PEST分析

第 5 章：經皮給藥系統市場 - 主要產業動態

  • 市場促進因素
    • 慢性病盛行率增加
    • 對非侵入性給藥設備的需求不斷成長
    • 自我用藥需求旺盛
  • 市場限制
    • 經皮給藥系統的不良反應與召回
  • 市場機會
    • 智慧補丁和 3D 列印補丁的進步
  • 未來的趨勢
    • 製造商的策略舉措
  • 影響分析

第 6 章：經皮給藥系統市場 - 全球市場分析

  • 經皮給藥系統市場收入，2022 - 2030

第 7 章：經皮給藥系統市場 - 收入和 2030 年預測 - 按產品

  • 概述
  • 2022 年和 2030 年按產品分類的經皮給藥系統市場收入佔有率 (%)
  • 經皮貼劑
  • 經皮凝膠
  • 經皮噴劑
  • 其他

第 8 章：全球經皮給藥系統市場 - 收入和 2030 年預測 -按應用

  • 概述
  • 2022 年和 2030 年按應用分列的經皮給藥系統市場收入佔有率 (%)
  • 心血管疾病
  • 中樞神經系統疾病
  • 疼痛管理
  • 荷爾蒙應用
  • 其他應用

第 9 章：全球經皮給藥系統市場 - 收入和 2030 年預測 - 按配銷通路

  • 概述
  • 2022 年和 2030 年按配銷通路的經皮給藥系統市場收入佔有率 (%)
  • 醫院藥房
  • 零售藥局
  • 網路藥局
  • 其他

第 10 章：經皮給藥系統市場 - 2030 年收入與預測 - 地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第 11 章：經皮給藥系統市場產業格局

  • 概述
  • 經皮給藥系統市場的成長策略
  • 無機成長策略
    • 概述
  • 有機成長策略
    • 概述

第 12 章：公司簡介

  • Novartis AG
  • Johnson & Johnson
  • GSK Plc
  • Viatris Inc
  • Boehringer Ingelheim International GmbH
  • Hisamitsu Pharmaceutical Co Inc
  • Luye Pharma Group Ltd
  • Lavipharm SA
  • Purdue Pharma LP
  • UCB SA

第 13 章：附錄

  • 關於我們
  • 專業術語
Product Code: TIPRE00002894

The global transdermal drug delivery systems market is expected to reach US$ 51.949 billion in 2030 from US$ 37.230 billion in 2022. The market is estimated to grow with a CAGR of 4.3% from 2022 to 2030.

The key factors driving the market's growth include growing areas of application of transdermal drug delivery systems and rising cases of spinal cord injury. However, the post-surgical complications hinder the market growth.

Market Opportunities of Transdermal Drug Delivery Systems Market

A transdermal drug administration route is novel and one of the reliable means of sustained drug delivery. With significant research being conducted in this field and the increasing interest of researchers in this form of drug delivery, a large number of transdermal patches are likely to reach the marketplace in the future. Transdermal patches are used to deliver drugs such as nicotine, fentanyl, nitroglycerin, and clonidine to treat various medical conditions. Recently, these patches have been explored to deliver biologics in various applications. Smart patches are equipped with sensors and other technologies to monitor patient conditions and adjust drug delivery accordingly. In January 2023, a lead scientist at Swansea University developed a new smart patch to detect proinflammatory biomarkers of neurodegenerative diseases such as Parkinson's and Alzheimer's using the microneedle technology. These smart patches comprise numerous microneedles designed to penetrate the skin barrier in a minimally invasive manner, followed by monitoring the biomarkers of clinical significance. They can be self-administered for point-of-care diagnosis at general practices or at home. This innovative research can potentially change the landscape of early neurodegenerative disease detection.

According to an article titled "3D-Printed Products for Topical Skin Applications: From Personalized Dressings to Drug Delivery," published in the National Library of Medicine in November 2021, personalized 3D-printed patches that conform to the skin surface can be used for acetyl-hexapeptide 3 (AHP-3) delivery. In this study, two liquid monomers-polyethylene glycol diacrylate (PEGDA) and vinylpyrrolidone (VP)-were used in different proportions to improve the mechanical strength, polymerization rate, and swelling rate of the final polymer. Optimal drug loading on the resin indicated that AHP-3 remained stable throughout the manufacturing process and had no effect on the physical properties of the final polymer. Using a 3D scanned facial model, a personalized patch was designed in computer-aided design software, and it was fabricated in optimized resin using a digital light processing 3D printer. The in-vitro characterization of prepared transdermal patches has shown their ability to penetrate human cadaver skin, further remaining intact upon compression. "3D-Printed Products for Topical Skin Applications: From Personalized Dressings to Drug Delivery" is the first study demonstrating personalized patches made using photopolymers, and it has introduced a novel approach to improve the transdermal delivery of drugs for effective wrinkle management.

Thus, the adoption of 3D printing technology and smart patches is likely to offer opportunities to the transdermal drug delivery systems market in the coming years.

Factors Hampering Transdermal Drug Delivery Systems Market

Currently marketed transdermal drug delivery systems (TDDS), transmucosal drug delivery systems (TMDS), and topical patches may retain 10-95% of the initial total quantity of the drug as a residual drug after the intended use period. This raises a potential safety issue for patients, and their family members and caregivers. For example, adverse events due to a patient's failure to remove TDDS at the end of the intended use period generally result in an increased or prolonged pharmacological effect of the drug. Some children have also been reported to have died from accidental exposure to discarded TDDS. Below are some of the product recalls and withdrawals by the manufacturers.

In February 2023, Aveva Drug Delivery Systems Inc recalled two lots of buprenorphine transdermal systems for failing to meet impurity/degradation specifications. Aveva Drug Delivery Systems voluntarily initiated the recall on February 15, 2023, which was designated as a Class III recall by the FDA on March 14, 2023. Under this recall classification, the use of the product is not likely to cause any major harm. In September 2020, Teva Pharmaceuticals USA recalled two lots of buprenorphine patches. The recall affected 32,543 cartons of buprenorphine transdermal systems, 5 mcg/hour, four transdermal systems per carton (patch NDC 0093-3656-21, carton NDC 0093-3656-40), from lots 190017 and 190161. The product was manufactured by 3M Drug Delivery Systems for Teva Pharmaceuticals and distributed in the US and Puerto Rico. Followed by its voluntary recall by Teva Pharmaceuticals on September 4, 2020, the FDA designated the recall Class II on October 1, 2020. Continuing the use of Class II recall products may cause temporary or medically reversible adverse health consequences if used. While remote, a possibility of serious harm exists. Further, in April 2018, the FDA sent a Warning Letter to Phase 4 Pharmaceutical LLC. Instead of manufacturing transdermal drug types, the firm was functioning as a re-packager of over-the-counter (OTC) transdermal drug types, and the FDA found several violations of CGMP that affected the quality of its products. In April 2019, Alvogen, Inc. announced a voluntary, nationwide recall of two lots (or batches) of Fentanyl Transdermal System, 12 mcg/h transdermal patches, because of a label mix-up. Thus, adverse effects and recalls of transdermal drug delivery systems hinder the market growth.

Transdermal Drug Delivery Systems Market: Segmental Overview

Based on product, the transdermal drug delivery system market is segmented into transdermal patches, transdermal gels, transdermal sprays, and others. The transdermal patch segment is further segmented into drug-in-adhesive patches, reservoir membrane patches, matrix patches, and vapor patches. The transdermal patches segment held the largest share of the market in 2022, while transdermal gels is anticipated to register the highest CAGR during 2022-2030. A transdermal patch is a drug delivery system attached to a patient's skin to deliver medication through the skin.

The transdermal drug delivery system market, by application, has been segmented into cardiovascular diseases, central nervous system disorders, hormonal applications, pain management, and other applications. The market for the pain management segment is sub-segmented into opioid application and non-opioid application. The market for hormonal application segment is further segmented into transdermal estrogen therapy and testosterone replacement therapy. The pain management segment held the largest share of the market in 2022. Central nervous system disorders segment is expected to register the highest CAGR in the market during 2022-2030.

Based on the distribution channel, the transdermal drug delivery system market is segmented into hospital pharmacies, retail pharmacies, online pharmacies, and others. The hospital pharmacies segment held the largest share of the market in 2022. However, the retail pharmacies segment is expected to register the highest CAGR in the market during 2022-2030.

Transdermal Drug Delivery Systems Market: Geographical Overview

North America accounted for the largest share of the global transdermal drug delivery systems market in 2022. In the region, the US held the largest transdermal drug delivery systems market share and is anticipated to register the highest CAGR during 2022-2030. According to the American Heart Association (AHA), cardiovascular disease (CVD) remains the leading cause of death in the US. According to the CDC, in 2021, CVD accounted for ~695,000 deaths and ~1 in 5 deaths in the US. The rising prevalence of cardiovascular disease, diabetes, chronic pain conditions, and other chronic diseases drives the demand for effective and convenient treatment options. Medical patches offer a noninvasive and patient-friendly approach to deliver medication and manage symptoms associated with these chronic conditions. Ongoing advancements in TDDS, such as wearable sensors and flexible electronics, contribute to the growth of the transdermal drug delivery system market. These advancements allow for more accurate dosing, enhanced patient monitoring, and improved patient compliance. According to a report titled "Recent advances in transdermal drug delivery systems," published by Biomaterials Research in 2021, microneedles attract significant attention among TDDS modalities, which overcome the limitations of the existing simple application type and patch-type needles by combining the advantages of microneedles to obtain higher treatment efficiency and effects. Advances in these TDDS can provide the driving force for controlling the prevalence of cardiovascular and central nervous system diseases, diabetes, neuromuscular diseases, and infectious and localized infectious diseases.

The growing trend of personalized medicines, where treatments are tailored to individual patients, has boosted the development of medical patches that offer controlled and targeted drug delivery. This customization allows for better patient outcomes and improved therapeutic efficacy. For instance, in 2020, Reddy's Laboratories launched an authorized generic version of NitroDur (nitroglycerin) transdermal infusion system in the US market. With the growing emphasis on home healthcare and remote patient monitoring, medical patches offer a convenient solution for delivering medications and monitoring vital signs outside traditional healthcare settings. The US transdermal drug delivery system market is influenced by factors such as the increasing prevalence of chronic diseases, rising technological advancements, and growing focus on personalized medicines.

A few of the major primary and secondary sources referred to while preparing the report on the transdermal drug delivery systems market are the World Bank Data, National Health Service (NHS), FDA (Food and Drug Administration), EMA (European Medicines Agency), and WHO (World Health Organization).

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the transdermal drug delivery systems market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global transdermal drug delivery systems market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the transdermal drug delivery systems market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Transdermal Drug Delivery System Market, by Geography (US$ Million)

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Transdermal Drug Delivery System Market Landscape

  • 4.1 Overview
  • 4.2 Global PEST Analysis

5. Transdermal Drug Delivery System Market - Key Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Prevalence of Chronic Diseases
    • 5.1.2 Growing Demand for Noninvasive Drug Delivery Devices
    • 5.1.3 High Demand for Self-Administration of Drugs
  • 5.2 Market Restraints
    • 5.2.1 Adverse Effects and Recall of Transdermal Drug Delivery Systems
  • 5.3 Market Opportunities
    • 5.3.1 Advancements in Smart Patches and 3D-Printed Patches
  • 5.4 Future Trends
    • 5.4.1 Strategic Initiatives by Manufacturers
  • 5.5 Impact Analysis

6. Transdermal Drug Delivery System Market - Global Market Analysis

  • 6.1 Transdermal Drug Delivery System Market Revenue (US$ Mn), 2022 - 2030

7. Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - by Product

  • 7.1 Overview
  • 7.2 Transdermal Drug Delivery System Market Revenue Share, by Product 2022 & 2030 (%)
  • 7.3 Transdermal Patches
    • 7.3.1 Overview
    • 7.3.2 Transdermal Patches: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.3.2.1 Drug-in-Adhesive Patches
        • 7.3.2.1.1 Overview
        • 7.3.2.1.2 Drug-in-Adhesive Patches: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.3.2.2 Matrix Patches
        • 7.3.2.2.1 Overview
        • 7.3.2.2.2 Matrix Patches: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.3.2.3 Reservoir Membrane Patches
        • 7.3.2.3.1 Overview
        • 7.3.2.3.2 Reservoir Membrane Patches: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.3.2.4 Vapor Patches
        • 7.3.2.4.1 Overview
        • 7.3.2.4.2 Vapor Patches: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Transdermal Gels
    • 7.4.1 Overview
    • 7.4.2 Transdermal Gels: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Transdermal Sprays
    • 7.5.1 Overview
    • 7.5.2 Transdermal Sprays: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)

8. Global Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - by Application

  • 8.1 Overview
  • 8.2 Transdermal Drug Delivery System Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Cardiovascular Diseases
    • 8.3.1 Overview
    • 8.3.2 Cardiovascular Diseases: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Central Nervous System Disorders
    • 8.4.1 Overview
    • 8.4.2 Central Nervous System Disorders: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Pain Management
    • 8.5.1 Overview
    • 8.5.2 Pain Management: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.5.2.1 Opioid
        • 8.5.2.1.1 Overview
        • 8.5.2.1.2 Opioid: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.5.2.2 Non-Opioid
        • 8.5.2.2.1 Overview
        • 8.5.2.2.2 Non-Opioid: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Hormonal Applications
    • 8.6.1 Overview
    • 8.6.2 Hormonal Applications: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.6.2.1 Transdermal Estrogen & Progesterone Therapy
        • 8.6.2.1.1 Overview
        • 8.6.2.1.2 Transdermal Estrogen & Progesterone Therapy: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.6.2.2 Testosterone Replacement
        • 8.6.2.2.1 Overview
        • 8.6.2.2.2 Testosterone Replacement: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Other Application
    • 8.7.1 Overview
    • 8.7.2 Other Application: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)

9. Global Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - by Distribution Channel

  • 9.1 Overview
  • 9.2 Transdermal Drug Delivery System Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • 9.3 Hospital Pharmacies
    • 9.3.1 Overview
    • 9.3.2 Hospital Pharmacies: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Retail Pharmacies
    • 9.4.1 Overview
    • 9.4.2 Retail Pharmacies: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Online Pharmacies
    • 9.5.1 Overview
    • 9.5.2 Online Pharmacies: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)

10. Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - Geographic Analysis

  • 10.1 North America: Transdermal Drug Delivery System Market
    • 10.1.1 Overview
    • 10.1.2 North America: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
    • 10.1.3 North America: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
      • 10.1.3.1 North America: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
    • 10.1.4 North America: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
      • 10.1.4.1 North America: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
      • 10.1.4.2 North America: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
    • 10.1.5 North America: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.1.5.1 US: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.5.1.1 Overview
        • 10.1.5.1.2 US: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.5.1.3 US: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.1.5.1.3.1 US: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.1.5.1.4 US: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.1.5.1.4.1 US: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.1.5.1.4.2 US: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.1.5.1.5 US: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.1.5.2 Canada: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.5.2.1 Overview
        • 10.1.5.2.2 Canada: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.5.2.3 Canada: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.1.5.2.3.1 Canada: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.1.5.2.4 Canada: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.1.5.2.4.1 Canada: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.1.5.2.4.2 Canada: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.1.5.2.5 Canada: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.1.5.3 Mexico: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.5.3.1 Overview
        • 10.1.5.3.2 Mexico: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.5.3.3 Mexico: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.1.5.3.3.1 Mexico: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.1.5.3.4 Mexico: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.1.5.3.4.1 Mexico: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.1.5.3.4.2 Mexico: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.1.5.3.5 Mexico: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
  • 10.2 Europe: Transdermal Drug Delivery System Market
    • 10.2.1 Overview
    • 10.2.2 Europe: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
    • 10.2.3 Europe: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
      • 10.2.3.1 Europe: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
    • 10.2.4 Europe: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
      • 10.2.4.1 Europe: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
      • 10.2.4.2 Europe: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
    • 10.2.5 Europe: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
    • 10.2.6 Europe: Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
      • 10.2.6.1 Germany: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.6.1.1 Overview
        • 10.2.6.1.2 Germany: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.6.1.3 Germany: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.2.6.1.3.1 Germany: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.2.6.1.4 Germany: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.2.6.1.4.1 Germany: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.2.6.1.4.2 Germany: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.2.6.1.5 Germany: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.2.6.2 France: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.6.2.1 Overview
        • 10.2.6.2.2 France: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.6.2.3 France: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.2.6.2.3.1 France: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.2.6.2.4 France: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.2.6.2.4.1 France: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.2.6.2.4.2 France: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.2.6.2.5 France: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.2.6.3 UK: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.6.3.1 Overview
        • 10.2.6.3.2 UK: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.6.3.3 UK: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.2.6.3.3.1 UK: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.2.6.3.4 UK: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.2.6.3.4.1 UK: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.2.6.3.4.2 UK: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.2.6.3.5 UK: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.2.6.4 Italy: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.6.4.1 Overview
        • 10.2.6.4.2 Italy: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.6.4.3 Italy: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.2.6.4.3.1 Italy: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.2.6.4.4 Italy: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.2.6.4.4.1 Italy: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.2.6.4.4.2 Italy: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.2.6.4.5 Italy: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.2.6.5 Spain: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.6.5.1 Overview
        • 10.2.6.5.2 Spain: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.6.5.3 Spain: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.2.6.5.3.1 Spain: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.2.6.5.4 Spain: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.2.6.5.4.1 Spain: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.2.6.5.4.2 Spain: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.2.6.5.5 Spain: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.2.6.6 Rest of Europe: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.6.6.1 Overview
        • 10.2.6.6.2 Rest of Europe: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.6.6.3 Rest of Europe: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.2.6.6.3.1 Rest of Europe: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.2.6.6.4 Rest of Europe: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.2.6.6.4.1 Rest of Europe: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.2.6.6.4.2 Rest of Europe: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.2.6.6.5 Rest of Europe: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
  • 10.3 Asia Pacific: Transdermal Drug Delivery System Market
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
    • 10.3.3 Asia Pacific: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
      • 10.3.3.1 Asia Pacific: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
    • 10.3.4 Asia Pacific: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
      • 10.3.4.1 Asia Pacific: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
      • 10.3.4.2 Asia Pacific: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
    • 10.3.5 Asia Pacific: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
    • 10.3.6 Asia Pacific: Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
      • 10.3.6.1 China: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.6.1.1 Overview
        • 10.3.6.1.2 China: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.6.1.3 China: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.3.6.1.3.1 China: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.3.6.1.4 China: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.3.6.1.4.1 China: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.3.6.1.4.2 China: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.3.6.1.5 China: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.3.6.2 Japan: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.6.2.1 Overview
        • 10.3.6.2.2 Japan: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.6.2.3 Japan: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.3.6.2.3.1 Japan: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.3.6.2.4 Japan: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.3.6.2.4.1 Japan: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.3.6.2.4.2 Japan: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.3.6.2.5 Japan: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.3.6.3 India: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.6.3.1 Overview
        • 10.3.6.3.2 India: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.6.3.3 India: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.3.6.3.3.1 India: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.3.6.3.4 India: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.3.6.3.4.1 India: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.3.6.3.4.2 India: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.3.6.3.5 India: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.3.6.4 Australia: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.6.4.1 Overview
        • 10.3.6.4.2 Australia: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.6.4.3 Australia: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.3.6.4.3.1 Australia: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.3.6.4.4 Australia: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.3.6.4.4.1 Australia: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.3.6.4.4.2 Australia: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.3.6.4.5 Australia: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.3.6.5 South Korea: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.6.5.1 Overview
        • 10.3.6.5.2 South Korea: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.6.5.3 South Korea: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.3.6.5.3.1 South Korea: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.3.6.5.4 South Korea: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.3.6.5.4.1 South Korea: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.3.6.5.4.2 South Korea: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.3.6.5.5 South Korea: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.3.6.6 Rest of Asia Pacific: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.6.6.1 Overview
        • 10.3.6.6.2 Rest of Asia Pacific: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.6.6.3 Rest of Asia Pacific: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.3.6.6.3.1 Rest of Asia Pacific: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.3.6.6.4 Rest of Asia Pacific: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.3.6.6.4.1 Rest of Asia Pacific: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.3.6.6.4.2 Rest of Asia Pacific: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.3.6.6.5 Rest of Asia Pacific: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
  • 10.4 Middle East & Africa Transdermal Drug Delivery System Market
    • 10.4.1 Overview
    • 10.4.2 Middle East & Africa: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
    • 10.4.3 Middle East & Africa: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
      • 10.4.3.1 Middle East & Africa: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
    • 10.4.4 Middle East & Africa: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
      • 10.4.4.1 Middle East & Africa: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
      • 10.4.4.2 Middle East & Africa: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
    • 10.4.5 Middle East & Africa: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.4.5.1 South Africa: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.5.1.1 Overview
        • 10.4.5.1.2 South Africa: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.5.1.3 South Africa: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.4.5.1.3.1 South Africa: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.4.5.1.4 South Africa: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.4.5.1.4.1 South Africa: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.4.5.1.4.2 South Africa: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.4.5.1.5 South Africa: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.4.5.2 Saudi Arabia: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.5.2.1 Overview
        • 10.4.5.2.2 Saudi Arabia: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.5.2.3 Saudi Arabia: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.4.5.2.3.1 Saudi Arabia: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.4.5.2.4 Saudi Arabia: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.4.5.2.4.1 Saudi Arabia: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.4.5.2.4.2 Saudi Arabia: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.4.5.2.5 Saudi Arabia: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.4.5.3 UAE: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.5.3.1 Overview
        • 10.4.5.3.2 UAE: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.5.3.3 UAE: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.4.5.3.3.1 UAE: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.4.5.3.4 UAE: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.4.5.3.4.1 UAE: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.4.5.3.4.2 UAE: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.4.5.3.5 UAE: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.4.5.4 Rest of Middle East & Africa: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.5.4.1 Overview
        • 10.4.5.4.2 Rest of Middle East & Africa: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.5.4.3 Rest of Middle East & Africa: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.4.5.4.3.1 Rest of Middle East & Africa: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.4.5.4.4 Rest of Middle East & Africa: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.4.5.4.4.1 Rest of Middle East & Africa: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.4.5.4.4.2 Rest of Middle East & Africa: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.4.5.4.5 Rest of Middle East & Africa: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
  • 10.5 South & Central America: Transdermal Drug Delivery System Market
    • 10.5.1 Overview
    • 10.5.2 South & Central America: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
    • 10.5.3 South & Central America: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
      • 10.5.3.1 South & Central America: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
    • 10.5.4 South & Central America: Transdermal Drug Delivery System Market, By Application, 2020-2030 (US$ Million)
      • 10.5.4.1 South & Central America: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
      • 10.5.4.2 South & Central America: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
    • 10.5.5 South & Central America: Transdermal Drug Delivery System Market, By Distribution Channel, 2020-2030 (US$ Million)
    • 10.5.6 South & Central America: Transdermal Drug Delivery System Market Share by Country - 2022 & 2030, (%)
      • 10.5.6.1 Brazil: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.5.6.1.1 Overview
      • 10.5.6.2 Brazil: Transdermal Drug Delivery System Market- Revenue and Forecasts to 2030 (US$ Million)
        • 10.5.6.2.1 Brazil: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.5.6.2.1.1 Brazil: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.5.6.2.2 Brazil: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.5.6.2.2.1 Brazil: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.5.6.2.2.2 Brazil: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.5.6.2.3 Brazil: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.5.6.3 Argentina: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.5.6.3.1 Overview
      • 10.5.6.4 Argentina: Transdermal Drug Delivery System Market- Revenue and Forecasts to 2030 (US$ Million)
        • 10.5.6.4.1 Argentina: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.5.6.4.1.1 Argentina: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.5.6.4.2 Argentina: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.5.6.4.2.1 Argentina: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.5.6.4.2.2 Argentina: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.5.6.4.3 Argentina: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.5.6.5 Rest of South & Central America: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.5.6.5.1 Overview
      • 10.5.6.6 Rest of South & Central America: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.5.6.6.1 Rest of South & Central America: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.5.6.6.1.1 Rest of South & Central America: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.5.6.6.2 Rest of South & Central America: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.5.6.6.2.1 Rest of South & Central America: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.5.6.6.2.2 Rest of South & Central America: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.5.6.6.3 Rest of South & Central America: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)

11. Transdermal Drug Delivery System Market Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Transdermal Drug Delivery System Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Novartis AG
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Johnson & Johnson
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 GSK Plc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Viatris Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Boehringer Ingelheim International GmbH
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Hisamitsu Pharmaceutical Co Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Luye Pharma Group Ltd
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Lavipharm SA
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Purdue Pharma LP
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 UCB SA
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Transdermal Drug Delivery System Market Segmentation
  • Table 2. North America Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. North America Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. North America Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. North America Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. North America Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. North America Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. US Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. US Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. US Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. US Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. US Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. US Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Canada Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Canada Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Canada Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Canada Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Canada Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Canada Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Mexico Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. Mexico Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Mexico Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. Mexico Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 24. Mexico Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 25. Mexico Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 26. Europe Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 27. Europe Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 28. Europe Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 29. Europe Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 30. Europe Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 31. Europe Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 32. Germany Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 33. Germany Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 34. Germany Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 35. Germany Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 36. Germany Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 37. Germany Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 38. France Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 39. France Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 40. France Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 41. France Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 42. France Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 43. France Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 44. UK Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 45. UK Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 46. UK Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 47. UK Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 48. UK Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 49. UK Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 50. Italy Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 51. Italy Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 52. Italy Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 53. Italy Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 54. Italy Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 55. Italy Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 56. Spain Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 57. Spain Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 58. Spain Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 59. Spain Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 60. Spain Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 61. Spain Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 62. Rest of Europe Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 63. Rest of Europe Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 64. Rest of Europe Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 65. Rest of Europe Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 66. Rest of Europe Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 67. Rest of Europe Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 68. Asia Pacific Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 69. Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 70. Asia Pacific Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 71. Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 72. Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 73. Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 74. China Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 75. China Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 76. China Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 77. China Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 78. China Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 79. China Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 80. Japan Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 81. Japan Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 82. Japan Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 83. Japan Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 84. Japan Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 85. Japan Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 86. India Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 87. India Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 88. India Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 89. India Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 90. India Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 91. India Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 92. Australia Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 93. Australia Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 94. Australia Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 95. Australia Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 96. Australia Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 97. Australia Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 98. South Korea Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 99. South Korea Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 100. South Korea Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 101. South Korea Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 102. South Korea Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 103. South Korea Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 104. Rest of Asia Pacific Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 105. Rest of Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 106. Rest of Asia Pacific Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 107. Rest of Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 108. Rest of Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 109. Rest of Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 110. Middle East & Africa Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 111. Middle East & Africa Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 112. Middle East & Africa Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 113. Middle East & Africa Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 114. Middle East & Africa Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 115. Middle East & Africa Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 116. South Africa Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 117. South Africa Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 118. South Africa Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 119. South Africa Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 120. South Africa Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 121. South Africa Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 122. Saudi Arabia Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 123. Saudi Arabia Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 124. Saudi Arabia Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 125. Saudi Arabia Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 126. Saudi Arabia Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 127. Saudi Arabia Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 128. UAE Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 129. UAE Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 130. UAE Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 131. UAE Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 132. UAE Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 133. UAE Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 134. Rest of Middle East & Africa Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 135. Rest of Middle East & Africa Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 136. Rest of Middle East & Africa Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 137. Rest of Middle East & Africa Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 138. Rest of Middle East & Africa Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 139. Rest of Middle East & Africa Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 140. South & Central America: Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 141. South & Central America Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 142. South & Central America: Transdermal Drug Delivery System Market, By Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 143. South & Central America Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 144. South & Central America Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 145. South & Central America: Transdermal Drug Delivery System Market, By Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 146. Brazil Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 147. Brazil Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 148. Brazil Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 149. Brazil Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 150. Brazil Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 151. Brazil Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 152. Argentina Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 153. Argentina Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 154. Argentina Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 155. Argentina Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 156. Argentina Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 157. Argentina Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 158. Rest of South & Central America Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 159. Rest of South & Central America Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 160. Rest of South & Central America Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 161. Rest of South & Central America Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 162. Rest of South & Central America Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 163. Rest of South & Central America Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 164. Recent Inorganic Growth Strategies in the Transdermal Drug Delivery System Market
  • Table 165. Recent Organic Growth Strategies in the Transdermal Drug Delivery System Market
  • Table 166. Glossary of Terms, Transdermal Drug Delivery System Market

List Of Figures

  • Figure 1. Transdermal Drug Delivery System Market Segmentation, By Geography
  • Figure 2. Global - PEST Analysis
  • Figure 3. Transdermal Drug Delivery System Market: Key Industry Dynamics
  • Figure 4. Transdermal Drug Delivery System Market: Impact Analysis of Drivers and Restraints
  • Figure 5. Transdermal Drug Delivery System Market Revenue (US$ Mn), 2020 - 2030
  • Figure 6. Global Transdermal Drug Delivery System Market, By Geography Forecast Analysis, 2022 & 2030
  • Figure 7. Transdermal Drug Delivery System Market Revenue Share, by Product 2022 & 2030 (%)
  • Figure 8. Transdermal Patches: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Drug-in-Adhesive Patches: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Matrix Patches: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Reservoir Membrane Patches: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Vapor Patches: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Transdermal Gels: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Transdermal Sprays: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Others: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Transdermal Drug Delivery System Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 17. Cardiovascular Diseases: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Central Nervous System Disorders: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Pain Management: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Opioid: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Non-Opioid: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Hormonal Applications: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Transdermal Estrogen & Progesterone Therapy: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Testosterone Replacement: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Other Application: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Transdermal Drug Delivery System Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • Figure 27. Hospital Pharmacies: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Retail Pharmacies: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Online Pharmacies: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 30. Others: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. North America: Transdermal Drug Delivery System Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 32. North America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 33. North America: Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
  • Figure 34. US: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 35. Canada: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 36. Mexico: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 37. Europe: Transdermal Drug Delivery System Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 38. Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 39. Europe: Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
  • Figure 40. Germany: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 41. France: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 42. UK: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 43. Italy: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 44. Spain: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 45. Rest of Europe: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 46. Asia Pacific: Transdermal Drug Delivery System Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 47. Asia Pacific Transdermal Drug Delivery System Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 48. Asia Pacific: Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
  • Figure 49. China: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 50. Japan: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 51. India: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 52. Australia: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 53. South Korea: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 54. Rest of Asia Pacific: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 55. Middle East & Africa: Transdermal Drug Delivery System Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 56. Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 57. Middle East & Africa: Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
  • Figure 58. South Africa: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 59. Saudi Arabia: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 60. UAE: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 61. Rest of Middle East & Africa: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 62. South & Central America: Transdermal Drug Delivery System Market, By Key Country - Revenue (2022) (US$ Million)
  • Figure 63. South & Central America: Transdermal Drug Delivery System Market- Revenue and Forecasts to 2030 (US$ Million)
  • Figure 64. South & Central America: Transdermal Drug Delivery System Market Share by Country - 2022 & 2030, (%)
  • Figure 65. Brazil: Transdermal Drug Delivery System Market- Revenue and Forecasts to 2030 (US$ Million)
  • Figure 66. Argentina: Transdermal Drug Delivery System Market- Revenue and Forecasts to 2030 (US$ Million)
  • Figure 67. Rest of South & Central America: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 68. Growth Strategies in the Transdermal Drug Delivery System Market